lincomycin has been researched along with epiglucan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, Y; Miura, NN; Nameda, S; Ohno, N | 1 |
1 other study(ies) available for lincomycin and epiglucan
Article | Year |
---|---|
Lincomycin protects mice from septic shock in beta-glucan-indomethacin model.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Blood Glucose; Cells, Cultured; Colon; Colony Count, Microbial; Cytokines; Feces; Gastrointestinal Tract; Indomethacin; Lincomycin; Male; Mice; Mice, Inbred ICR; Prednisolone; Schizophyllum; Shock, Septic; Spleen | 2007 |